The Manulife-Loblaw deal: How it will impact you and other questions, answered | CBC News
Briefly

The deal could hurt independent pharmacies and degrade the quality of pharmaceutical care that patients receive, while others said the arrangement is good for Canada's competition landscape and that patients will benefit from lower costs.
The deal will impact only people whose specialty drug prescriptions are covered by Manulife. If you have a prescription that's not for a specialty drug, the arrangement won't affect you.
Read at www.cbc.ca
[
]
[
|
]